Tobira Therapeutics

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Tobira Therapeutics - overview

Established

2006

Location

South San Francisco, CA-California, US

Primary Industry

Pharmaceuticals

About

Established in 2006, Tobira Therapeutics is a biopharmaceutical company based in California, US. The firm engages in the development and commercialization of antiviral compounds for HIV treatment.


Current Investors

Domain Associates, Frazier Healthcare Partners, Canaan Partners

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development

Website

www.tobiratherapeutics.com

Total Amount Raised

Subscriber access only

Tobira Therapeutics - financials

Fiscal Year EndedDec 31, 2013Dec 31, 2014Dec 30, 2015
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Tobira Therapeutics - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
MergerCompletedRegado Biosciences, Inc.-
PIPECompletedTobira Therapeutics, Inc.-
Unspecified RoundCompletedTobira Therapeutics, Inc.-
Venture DebtCompletedTobira Therapeutics, Inc.-
Series BCompletedTobira Therapeutics, Inc.-

Displaying 1 - 5 of 8

Tobira Therapeutics - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.